US 11180529
Alpha-v beta-6 integrin ligands and uses thereof
granted A61KA61K31/713A61K38/08
Quick answer
US patent 11180529 (Alpha-v beta-6 integrin ligands and uses thereof) held by Arrowhead Pharmaceuticals, Inc. expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/713, A61K38/08, A61K47/60, A61K47/64